Radar Therapeutics
Radar Therapeutics is pioneering a new treatment modality: precision-expressed mRNA-based therapeutics. Founded by pioneers in synthetic biology, the company leverages single-cell transcriptomic data, RNA-editing enzymes, and logic gates to create smart mRNAs that can read cell information in real time and reprogram cells with high precision. Their platform enables reading the cell state before writing a new function, allowing for targeted, timely, and controlled therapeutic interventions that avoid side effects and are scalable. The company's mission is to develop safe, effective, programmable RNA therapies that can target the right cells at the right time, revolutionizing treatment for intractable diseases.
Industries
Nr. of Employees
small (1-50)
Radar Therapeutics
Products
Platform for precision-controlled mRNA therapeutics
A research and development platform that integrates transcriptomic target discovery, programmable RNA sensors, RNA-editing-based sensing mechanisms, and genetic circuits to enable selective, timed expression of mRNA therapeutics in desired cell types.
RADAR platform
A platform enabling precision therapeutics through targeted, timely, and controlled reading of the mRNA message in just the right cells, avoiding toxic side-effects in non-target cells.
Platform for precision-controlled mRNA therapeutics
A research and development platform that integrates transcriptomic target discovery, programmable RNA sensors, RNA-editing-based sensing mechanisms, and genetic circuits to enable selective, timed expression of mRNA therapeutics in desired cell types.
RADAR platform
A platform enabling precision therapeutics through targeted, timely, and controlled reading of the mRNA message in just the right cells, avoiding toxic side-effects in non-target cells.
Services
Collaborative R&D and preclinical programs focused on computational target identification, design of programmable RNA sensors and mRNA constructs, and preclinical functional testing.
Collaborative R&D and preclinical programs focused on computational target identification, design of programmable RNA sensors and mRNA constructs, and preclinical functional testing.
Expertise Areas
- Programmable RNA sensor development
- mRNA therapeutic design and engineering
- Single-cell transcriptomics analytics and target discovery
- Genetic circuit and translational control engineering
Key Technologies
- mRNA therapeutics
- ADAR-mediated RNA editing
- Programmable RNA sensors
- Single-cell RNA-seq analytics
News & Updates
Recent news and updates about Radar Therapeutics, including awards, recognitions, and collaborations.
Radar Therapeutics announced the launch of their targeted treatment platform.
The company raised seed funding to develop smart programmable medicines using molecular RNA sensors.
Recognition for Radar's CEO for leadership and impact.
Recognition for innovative discovery in biotech.
Award for diversity, inclusion, and belonging.
Recent news and updates about Radar Therapeutics, including awards, recognitions, and collaborations.
Radar Therapeutics announced the launch of their targeted treatment platform.
The company raised seed funding to develop smart programmable medicines using molecular RNA sensors.
Recognition for Radar's CEO for leadership and impact.
Recognition for innovative discovery in biotech.
Award for diversity, inclusion, and belonging.